CClinicalTrials.gg
CompletedNCT05297071Updated Feb 28, 2024

Longitudinal Monitoring of Microsurgical Socket Augmentation Healing With Ultrasonography

An interventional study of Orascopic HDL 3.0 Loupes and Semorr DOM3000D Operation Microscope in Healing Wound, sponsored by University of Michigan. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-02-28.

Sponsored by University of Michigan · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this study is to assess healing after tooth extraction with simultaneous socket augmentation (bone grafting during the same appointment as the extraction) when the surgeon uses a surgical microscope, compared to when the surgeon uses dental loupes (magnifiers that are mounted on the surgeon's glasses). These devices magnify and shine light on the area where the surgeon operates.

Read the detailed description

After a tooth is extracted, a hole is left in the bone called a socket. During the first year of healing after a tooth extraction, there may be up to 60% loss of bone volume at the site. Loss of bone at the edentulous ridge (toothless area) may make it more difficult to place dental implants later. Dental socket grafting is performed to reduce bone resorption after tooth extraction. Grafting involves filling the socket with bone graft (donated human cadaver derived) and covering it with a protective collagen membrane. This graft prevents resorption of the ridge and is slowly replaced with the patient's own bone. The investigators will be trying to determine if bone healing is better if the surgeon uses more powerful magnification.

02

Conditions studied

  • Healing Wound
03

In context

Lead sponsor

University of Michigan is the lead sponsor of 1,475 studies on the registry; 196 are open to participants now.

Of its 162 completed or terminated interventional studies of FDA-regulated products, 128 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. At least 18 years of age
  2. Single maxillary or mandibular hopeless tooth (a maxillary or mandibular anterior tooth or premolar) planned for extraction due to periapical pathology with a minimum ≥2 mm of the size of the periapical radiolucency shown on a peri-apical film.
  3. The patient is planned for implant restoration for the hopeless tooth
  4. The study site allows for implant placement with or without additional bone augmentation procedures after the healing
  5. Adequate edentulous space for the final restoration on the implant

Exclusion criteria

Exclusion Criteria:

  1. Current smokers or quit smoking less than 6 months
  2. Major or uncontrolled medical conditions, e.g. poorly controlled diabetes mellitus (HbA1c >8.0%, uncontrolled systemic disease or condition known to alter bone metabolism, e.g. osteoporosis, osteopenia, hyperparathyroidism, Paget's disease, etc.
  3. Pregnancy, breast-feeding, could be pregnant or planning to become pregnant in the next 4 months (self-reported)
  4. Taking medications known to modify bone metabolism (i.e. bisphosphonates, corticosteroids, hormone replacement therapy)
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
40 participants (actual)

Study arms

  • Other
    Dental Loupes

    The surgeon will use dental loupes with a head lamp during the subject's tooth extraction and socket grafting.

    Device: Orascopic HDL 3.0 Loupes

  • Other
    Surgical microscope

    The surgeon will use a surgical microscope (with built-in lighting) during the subject's tooth extraction and socket grafting.

    Device: Semorr DOM3000D Operation Microscope

Interventions

  • DeviceOrascopic HDL 3.0 Loupes

    The loupes will be used during the surgical procedure on half of the subjects. The other half will be performed with a microscope.

  • DeviceSemorr DOM3000D Operation Microscope

    The microscope will be used during the surgical procedure on half of the subjects. The other half will be performed with loupes.

06

What researchers measure

Primary outcomes

  1. Bone quality

    Difference in bone density from the CBCT and ultrasound

    Time frame: 12 weeks

Secondary outcomes

  1. Patient-reported outcomes

    Difference in patient-reported outcomes. Subjects will be given a questionnaire to evaluate pain perception, pain medication use, and complications after surgery.

    Time frame: 1 week, 2 weeks, and 4 weeks

07

Study locations

1 site
  • University of Michigan School of Dentistry
    Ann Arbor, Michigan 48109, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 28, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05297071
Lead sponsor
University of Michigan
Collaborators
Delta Dental Foundation
Responsible party
Hsun-Liang Chan (Assistant Program Director, Periodontics Graduate Program, University of Michigan) — Principal investigator
First posted
Mar 25, 2022
Start date
Mar 22, 2022
Primary completion
Jun 26, 2023
Completion
Jul 21, 2023
Last update
Feb 28, 2024

Study contacts

Hsun-Liang Chan, DDS, MS
principal investigator · University of Michigan

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion